Skip to content
  • 6,719 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Combined synopsis and solicitation

Atropine & Pralidoxime Chloride Injector, Single Dose Auto- Injectors

75A50324R00005

Office of Assistant Secretary for Preparedness and Response, Aspr/Orm-Sns. Pharmaceutical Preparation Manufacturing.

9 open like this View on SAM.gov Markdown

Awarded

Meridian Medical Technologies, LLC

$82,223,186.40 obligated so far on USAspending

Get the next one like this from Office of Assistant Secretary for Preparedness and Response by email, the day it is posted.Find my opportunities

This one was awarded in 2024

9 like it are open now in pharmaceutical preparation manufacturing

All 9 open in pharmaceutical preparation manufacturing

Description

As published on SAM.gov.

The Strategic National Stockpile (SNS), of the U.S. Department of Health and Human Services (HHS) Office of the Administration for Strategic Preparedness and Response (ASPR), has a requirement for Atropine & Pralidoxime Chloride Injector, Single Dose Auto-Injectors. Refer to attached request for proposal (RFP).

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Meridian Medical Technologies, LLC
UEI
VBM4PLZ9VBC4
CAGE
54452
Vendor location
Saint Louis, MO
Contract
75A50324C00015, definitive contract
Obligated
$82,223,186.40, potential $129,680,170
Actions
3 between September 27, 2024 and September 18, 2025
Competition
Full and Open Competition, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Atropine & Pralidoxime Chloride Injector, Single Dose Auto-Injectors
Match
solicitation number 75A50324R00005 equals the FPDS solicitation identifier; same awarding office 75A503 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 7, 2024

    Combined synopsis and solicitation

    Due August 22, 2024 at 4:00 PM EDT. SAM.gov, notice 30ab6f2e83cb477e8b42873b57c02b6b

Points of contact